Guanhao Biotech Co., Ltd.

31
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001575
CNY
14.99
-1.6 (-9.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
383.00
374.00
402.00
375.00
484.00
434.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
383.00
374.00
402.00
375.00
484.00
434.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
4.00
1.00
3.00
5.00
9.00
14.00
General and Administration Expenses
206.00
212.00
217.00
203.00
230.00
224.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
349.00
335.00
360.00
356.00
416.00
390.00
Operating Profit (PBDIT) excl Other Income
34.00
39.00
42.00
18.00
67.00
43.00
Other Income
0.00
10.00
3.00
26.00
32.00
23.00
Operating Profit (PBDIT)
55.00
73.00
73.00
13.00
146.00
97.00
Interest
4.00
1.00
3.00
5.00
9.00
14.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
26.00
27.00
34.00
41.00
49.00
35.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
25.00
27.00
32.00
-281.00
86.00
48.00
Provision for Tax
12.00
11.00
11.00
35.00
31.00
3.00
Profit After Tax
24.00
27.00
31.00
-307.00
73.00
46.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.09
0.10
0.12
-1.16
0.28
0.18
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 2.25% vs -6.76% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -12.38% vs -6.86% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 121.48% vs -42.75% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is -11.20% vs -11.57% in Dec 2024

Compare Profit and Loss Results of Guanhao Biotech Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
Operating Income
383.00
0
383.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
383.00
0
383.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
0.00
0
0.00
0%
Operating Expenses
4.00
0
4.00
0%
General and Administration Expenses
206.00
0
206.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
349.00
0
349.00
0%
Operating Profit (PBDIT) excl Other Income
34.00
0.00
34.00
0%
Other Income
0.00
0
0.00
0%
Operating Profit (PBDIT)
55.00
0
55.00
0%
Interest
4.00
0
4.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
26.00
0
26.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
25.00
0
25.00
0%
Provision for Tax
12.00
0
12.00
0%
Profit After Tax
24.00
0
24.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.0918
0
0.09
0%
Profit And Loss - Net Sales
Net Sales 383.42 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 2.25% vs -6.76% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 34.35 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -12.38% vs -6.86% in Dec 2024

Profit And Loss - Interest
Interest 4.22 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 121.48% vs -42.75% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax 24.35 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -11.20% vs -11.57% in Dec 2024